Bright Minds Biosciences Inc. rose 23.1% on Tuesday, November 10, 2026, on 252 shares. No headline about DRUG came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Bright Minds Biosciences Inc. (DRUG:CSE) closed at $32.75 on November 13, 2026, down 0.76% on the day. The stock trades 80.7% below its 52-week high of $170.00 and 26.2% above its 52-week low of $25.95. Over the past year, it lost 59.6%. Bright Minds Biosciences Inc. is part of the Life Sciences sector.
In 252 trading sessions since November 13, 2025, DRUG closed higher on 108 days (43%). Its best day was November 10, 2026 (+23.08%) and its worst was November 2, 2026 (-51.97%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 10 times.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Find more stocks like DRUG with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.